Wilm’s Tumor (WT1)

Antiboby targets epitope expressed in Wilms tumor, fetal and adult kidney, developing ovary, and testis, but not in endometrial, cervical epithelium and mesothelioma. It is mainly used for the differential diagnosis of epithelioid mesothelioma and adenocarcinoma, and for the differential diagnosis of ovarian and peritoneal serous carcinoma and of the uterine serous carcinoma.